Cargando…
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron’s attenuated clinical sev...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413704/ https://www.ncbi.nlm.nih.gov/pubmed/36032973 http://dx.doi.org/10.1101/2022.08.19.22278993 |
_version_ | 1784775815156727808 |
---|---|
author | Sun, Kaiyuan Tempia, Stefano Kleynhans, Jackie von Gottberg, Anne McMorrow, Meredith L Wolter, Nicole Bhiman, Jinal N. Moyes, Jocelyn Carrim, Maimuna Martinson, Neil A Kahn, Kathleen Lebina, Limakatso du Toit, Jacques D. Mkhencele, Thulisa Viboud, Cécile Cohen, Cheryl |
author_facet | Sun, Kaiyuan Tempia, Stefano Kleynhans, Jackie von Gottberg, Anne McMorrow, Meredith L Wolter, Nicole Bhiman, Jinal N. Moyes, Jocelyn Carrim, Maimuna Martinson, Neil A Kahn, Kathleen Lebina, Limakatso du Toit, Jacques D. Mkhencele, Thulisa Viboud, Cécile Cohen, Cheryl |
author_sort | Sun, Kaiyuan |
collection | PubMed |
description | South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron’s attenuated clinical severity, and an increased risk of reinfection, the size of the Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly understood in South Africa and in many other countries. Using South African data from urban and rural cohorts closely monitored since the beginning of the pandemic, we analyzed sequential serum samples collected before, during, and after the Omicron BA.1/2 wave to infer infection rates and monitor changes in the immune histories of participants over time. Omicron BA.1/2 infection attack rates reached 65% (95% CI, 60% – 69%) in the rural cohort and 58% (95% CI, 61% – 74%) in the urban cohort, with repeat infections and vaccine breakthroughs accounting for >60% of all infections at both sites. Combined with previously collected data on pre-Omicron variant infections within the same cohorts, we identified 14 distinct categories of SARS-CoV-2 antigen exposure histories in the aftermath of the Omicron BA.1/2 wave, indicating a particularly fragmented immunologic landscape. Few individuals (<6%) remained naïve to SARS-CoV-2 and no exposure history category represented over 25% of the population at either cohort site. Further, cohort participants were more than twice as likely to get infected during the Omicron BA.1/2 wave, compared to the Delta wave. Prior infection with the ancestral strain (with D614G mutation), Beta, and Delta variants provided 13% (95% CI, −21% – 37%), 34% (95% CI, 17% – 48%), and 51% (95% CI, 39% – 60%) protection against Omicron BA.1/2 infection, respectively. Hybrid immunity (prior infection and vaccination) and repeated prior infections (without vaccination) reduced the risks of Omicron BA.1/2 infection by 60% (95% CI, 42% – 72%) and 85% (95% CI, 76% – 92%) respectively. Reinfections and vaccine breakthroughs had 41% (95% CI, 26% – 53%) lower risk of onward transmission than primary infections. Our study sheds light on a rapidly shifting landscape of population immunity, along with the changing characteristics of SARS-CoV-2, and how these factors interact to shape the success of emerging variants. Our findings are especially relevant to populations similar to South Africa with low SARS-CoV-2 vaccine coverage and a dominant contribution of immunity from prior infection. Looking forward, the study provides context for anticipating the long-term circulation of SARS-CoV-2 in populations no longer naïve to the virus. |
format | Online Article Text |
id | pubmed-9413704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-94137042022-08-27 Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa Sun, Kaiyuan Tempia, Stefano Kleynhans, Jackie von Gottberg, Anne McMorrow, Meredith L Wolter, Nicole Bhiman, Jinal N. Moyes, Jocelyn Carrim, Maimuna Martinson, Neil A Kahn, Kathleen Lebina, Limakatso du Toit, Jacques D. Mkhencele, Thulisa Viboud, Cécile Cohen, Cheryl medRxiv Article South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron’s attenuated clinical severity, and an increased risk of reinfection, the size of the Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly understood in South Africa and in many other countries. Using South African data from urban and rural cohorts closely monitored since the beginning of the pandemic, we analyzed sequential serum samples collected before, during, and after the Omicron BA.1/2 wave to infer infection rates and monitor changes in the immune histories of participants over time. Omicron BA.1/2 infection attack rates reached 65% (95% CI, 60% – 69%) in the rural cohort and 58% (95% CI, 61% – 74%) in the urban cohort, with repeat infections and vaccine breakthroughs accounting for >60% of all infections at both sites. Combined with previously collected data on pre-Omicron variant infections within the same cohorts, we identified 14 distinct categories of SARS-CoV-2 antigen exposure histories in the aftermath of the Omicron BA.1/2 wave, indicating a particularly fragmented immunologic landscape. Few individuals (<6%) remained naïve to SARS-CoV-2 and no exposure history category represented over 25% of the population at either cohort site. Further, cohort participants were more than twice as likely to get infected during the Omicron BA.1/2 wave, compared to the Delta wave. Prior infection with the ancestral strain (with D614G mutation), Beta, and Delta variants provided 13% (95% CI, −21% – 37%), 34% (95% CI, 17% – 48%), and 51% (95% CI, 39% – 60%) protection against Omicron BA.1/2 infection, respectively. Hybrid immunity (prior infection and vaccination) and repeated prior infections (without vaccination) reduced the risks of Omicron BA.1/2 infection by 60% (95% CI, 42% – 72%) and 85% (95% CI, 76% – 92%) respectively. Reinfections and vaccine breakthroughs had 41% (95% CI, 26% – 53%) lower risk of onward transmission than primary infections. Our study sheds light on a rapidly shifting landscape of population immunity, along with the changing characteristics of SARS-CoV-2, and how these factors interact to shape the success of emerging variants. Our findings are especially relevant to populations similar to South Africa with low SARS-CoV-2 vaccine coverage and a dominant contribution of immunity from prior infection. Looking forward, the study provides context for anticipating the long-term circulation of SARS-CoV-2 in populations no longer naïve to the virus. Cold Spring Harbor Laboratory 2022-08-22 /pmc/articles/PMC9413704/ /pubmed/36032973 http://dx.doi.org/10.1101/2022.08.19.22278993 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Sun, Kaiyuan Tempia, Stefano Kleynhans, Jackie von Gottberg, Anne McMorrow, Meredith L Wolter, Nicole Bhiman, Jinal N. Moyes, Jocelyn Carrim, Maimuna Martinson, Neil A Kahn, Kathleen Lebina, Limakatso du Toit, Jacques D. Mkhencele, Thulisa Viboud, Cécile Cohen, Cheryl Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa |
title | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa |
title_full | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa |
title_fullStr | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa |
title_full_unstemmed | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa |
title_short | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa |
title_sort | rapidly shifting immunologic landscape and severity of sars-cov-2 in the omicron era in south africa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413704/ https://www.ncbi.nlm.nih.gov/pubmed/36032973 http://dx.doi.org/10.1101/2022.08.19.22278993 |
work_keys_str_mv | AT sunkaiyuan rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT tempiastefano rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT kleynhansjackie rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT vongottberganne rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT mcmorrowmeredithl rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT wolternicole rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT bhimanjinaln rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT moyesjocelyn rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT carrimmaimuna rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT martinsonneila rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT kahnkathleen rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT lebinalimakatso rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT dutoitjacquesd rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT mkhencelethulisa rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT viboudcecile rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT cohencheryl rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica AT rapidlyshiftingimmunologiclandscapeandseverityofsarscov2intheomicronerainsouthafrica |